Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.
about
Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Hematologic and renal improvem ...... ith bortezomib-based regimens.
@en
Hematologic and renal improvem ...... ith bortezomib-based regimens.
@nl
type
label
Hematologic and renal improvem ...... ith bortezomib-based regimens.
@en
Hematologic and renal improvem ...... ith bortezomib-based regimens.
@nl
prefLabel
Hematologic and renal improvem ...... ith bortezomib-based regimens.
@en
Hematologic and renal improvem ...... ith bortezomib-based regimens.
@nl
P2093
P2860
P1433
P1476
Hematologic and renal improvem ...... ith bortezomib-based regimens.
@en
P2093
Charis Matsouka
Demetrios V Vlahakos
Despoina Fotiou
Despoina Spanomichou
Dimitrios C Ziogas
Eftychia Kafantari
Erasmia Psimenou
Evangelos Eleutherakis-Papaiakovou
Evangelos Terpos
Hariklia Gakiopoulou
P2860
P304
P356
10.1080/10428194.2016.1267349
P577
2016-12-14T00:00:00Z